Humacyte Inc
NASDAQ:HUMA

Watchlist Manager

Humacyte Inc

NASDAQ:HUMA

Watchlist

Dividends

Price: 2.31 USD -7.97% Market Closed

Market Cap: 358.3m USD

Have any thoughts about
Humacyte Inc?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Chevron Corp NYSE:CVX	Energy

Add Price Alert

Price Target:

Last Price: 2.31 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

HUMA Alert

Humacyte Inc

2.31

-0.20 (-7.97%)

52 Week Range	1.15 9.46
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US
	Chevron Corp NYSE:CVX	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Humacyte Inc

What unique competitive advantages
does Humacyte Inc hold over its rivals?

What risks and challenges
does Humacyte Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Humacyte Inc.

What unique competitive advantages
does Humacyte Inc hold over its rivals?

What risks and challenges
does Humacyte Inc face in the near future?

Has there been any significant insider trading activity
in Humacyte Inc recently?

Summarize the latest earnings call
of Humacyte Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Humacyte Inc.

Provide P/S
for Humacyte Inc.

Provide P/E
for Humacyte Inc.

Provide P/OCF
for Humacyte Inc.

Provide P/FCFE
for Humacyte Inc.

Provide P/B
for Humacyte Inc.

Provide EV/S
for Humacyte Inc.

Provide EV/GP
for Humacyte Inc.

Provide EV/EBITDA
for Humacyte Inc.

Provide EV/EBIT
for Humacyte Inc.

Provide EV/OCF
for Humacyte Inc.

Provide EV/FCFF
for Humacyte Inc.

Provide EV/IC
for Humacyte Inc.

Show me price targets
for Humacyte Inc made by professional analysts.

What are the Revenue projections
for Humacyte Inc?

How accurate were the past Revenue estimates
for Humacyte Inc?

What are the Net Income projections
for Humacyte Inc?

How accurate were the past Net Income estimates
for Humacyte Inc?

What are the EPS projections
for Humacyte Inc?

How accurate were the past EPS estimates
for Humacyte Inc?

What are the EBIT projections
for Humacyte Inc?

How accurate were the past EBIT estimates
for Humacyte Inc?

Compare the revenue forecasts
for Humacyte Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Humacyte Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Humacyte Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Humacyte Inc compared to its peers.

Compare the P/E ratios
of Humacyte Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Humacyte Inc with its peers.

Analyze the financial leverage
of Humacyte Inc compared to its main competitors.

Show all profitability ratios
for Humacyte Inc.

Provide ROE
for Humacyte Inc.

Provide ROA
for Humacyte Inc.

Provide ROIC
for Humacyte Inc.

Provide ROCE
for Humacyte Inc.

Provide Gross Margin
for Humacyte Inc.

Provide Operating Margin
for Humacyte Inc.

Provide Net Margin
for Humacyte Inc.

Provide FCF Margin
for Humacyte Inc.

Show all solvency ratios
for Humacyte Inc.

Provide D/E Ratio
for Humacyte Inc.

Provide D/A Ratio
for Humacyte Inc.

Provide Interest Coverage Ratio
for Humacyte Inc.

Provide Altman Z-Score Ratio
for Humacyte Inc.

Provide Quick Ratio
for Humacyte Inc.

Provide Current Ratio
for Humacyte Inc.

Provide Cash Ratio
for Humacyte Inc.

What is the historical Revenue growth
over the last 5 years for Humacyte Inc?

What is the historical Net Income growth
over the last 5 years for Humacyte Inc?

What is the current Free Cash Flow
of Humacyte Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Humacyte Inc.

Section:

Wall Street
Price Targets

HUMA Price Targets Summary
Humacyte Inc

Wall Street analysts forecast HUMA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HUMA is 9.62 USD with a low forecast of 3.03 USD and a high forecast of 26.25 USD.

HUMA Average Forecast

Wall Street Target

9.62 USD

316% Upside

HUMA Highest Forecast

Wall Street Target

26.25 USD

1 036% Upside

Lowest

Price Target

3.03 USD

31% Upside

Average

Price Target

9.62 USD

316% Upside

Highest

Price Target

26.25 USD

1 036% Upside

Humacyte Inc Competitors:
Price Targets

086900

Medy Tox Inc

31% Upside

CRBU

Caribou Biosciences Inc

436% Upside

688105

Nanjing Vazyme Biotech Co Ltd

7% Upside

GILD

Gilead Sciences Inc

9% Upside

086900

Medy Tox Inc

31% Upside

CRBU

Caribou Biosciences Inc

436% Upside

688105

Nanjing Vazyme Biotech Co Ltd

7% Upside

GILD

Gilead Sciences Inc

9% Upside

VITR

Vitrolife AB

50% Upside

ASND

Ascendis Pharma A/S

30% Upside

ALDX

Aldeyra Therapeutics Inc

90% Upside

PRAX

Praxis Precision Medicines Inc

98% Upside

Revenue
Forecast

Revenue Estimate
Humacyte Inc

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average

What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Humacyte Inc

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-2%

Average Miss

What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Humacyte Inc

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-76%

Average Miss

What are analyst estimates?

What is HUMA's stock price target?

Price Target
9.62 USD

According to Wall Street analysts, the average 1-year price target for HUMA is 9.62 USD with a low forecast of 3.03 USD and a high forecast of 26.25 USD.

	Franklin Covey Co NYSE:FC	20.85 USD 0.14%
	Mohawk Industries Inc NYSE:MHK	112.67 USD -1.02%
	Ardmore Shipping Corp NYSE:ASC	10.45 USD 0.87%
	ASGN Inc NYSE:ASGN	48.87 USD -3.27%
	Skyworks Solutions Inc NASDAQ:SWKS	75.42 USD -2.93%
	Weatherford International PLC NASDAQ:WFRD	57.95 USD 1.22%

	Johnson & Johnson NYSE:JNJ	156.9 USD -0.5%
	Bank of America Corp NYSE:BAC	46.73 USD -0.51%
	Mastercard Inc NYSE:MA	550.18 USD -2.37%
	Salesforce Inc NYSE:CRM	258.07 USD -2.24%
	Abbvie Inc NYSE:ABBV	192.45 USD -1.31%
	Home Depot Inc NYSE:HD	370.07 USD -0.87%

	Monolithic Power Systems Inc NASDAQ:MPWR	736.06 USD -0.59%
	NVIDIA Corp NASDAQ:NVDA	164.92 USD 0.5%
	Pro Medicus Ltd ASX:PME	317.34 AUD -0.11%
P	Plover Bay Technologies Ltd HKEX:1523	6.15 HKD 0.65%
S	SciClone Pharmaceuticals (Holdings) Ltd HKEX:6600	18.72 HKD
	Alfa Financial Software Holdings PLC LSE:ALFA	218.5 GBX -0.68%

	Salesforce Inc NYSE:CRM	258.07 USD -2.24%
	Accenture PLC NYSE:ACN	281.06 USD -2.53%
	ServiceNow Inc NYSE:NOW	938.78 USD -3.03%
	Spotify Technology SA NYSE:SPOT	709.15 USD -0.11%
	EOG Resources Inc NYSE:EOG	123.04 USD 1.08%
	Monster Beverage Corp NASDAQ:MNST	58.83 USD -0.57%

Humacyte Inc
NASDAQ:HUMA